LINC-ROR: A Potential Drug Target and Biomarker (G100885779)

Target Name: LINC-ROR

NCBI ID: G100885779

LINC-ROR

LINC-ROR: A Potential Drug Target and Biomarker

LINC-ROR, a gene known for its role in the development and progression of various diseases, has recently emerged as a promising drug target and biomarker. Its unique structure and function have piqued the interest of researchers, and a growing body of research is beginning to uncover the potential applications of this gene in drug development and personalized medicine.

The LINC-ROR gene is located on chromosome 12q34 and encodes a protein known as RNA-binding protein LINC-ROR. This protein plays a crucial role in the regulation of gene expression and has been linked to the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of LINC-ROR is its ability to interact with other proteins and RNA molecules. This interaction has led to the formation of a complex with the protein Myr1, which is a key regulator of microRNA (miRNA) levels. This complex plays a role in the regulation of gene expression and has been implicated in the development and progression of various diseases.

In addition to its role in gene regulation, LINC-ROR has also been shown to play a key role in the development of cancer. Studies have shown that LINC-ROR levels are often elevated in cancer cells and that inhibiting its activity can lead to the regression of cancer tumors. This suggests that LINC-ROR may be a valuable drug target for cancer treatment.

Another potential application of LINC-ROR is its role as a biomarker. The expression of LINC-ROR has been shown to be elevated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that LINC-ROR may be a useful biomarker for these diseases and could be used in the development of personalized medicine.

In addition to its potential as a drug target and biomarker, LINC-ROR is also of interest due to its unique structure. The LINC-ROR gene is composed of a unique open-loop structure, which is not found in other genes. This structure is thought to be involved in the regulation of gene expression and has implications for the development of new therapeutic approaches.

Overall, LINC-ROR is a promising drug target and biomarker that has the potential to revolutionize our understanding of disease development and treatment. Further research is needed to fully understand its functions and potential applications, but its unique structure and function have already piqued the interest of researchers and promises to be a valuable tool in the development of personalized medicine.

Protein Name: Long Intergenic Non-protein Coding RNA, Regulator Of Reprogramming

The "LINC-ROR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC-ROR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets